ReP USP - Resultado da busca

Artigo de periodico
Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson’s disease, results from a phase II randomised controlled trial (2024)
Moraes, Íbis Ariana Peña de ; Collett, Johnny; Silva, Talita Dias da ; Franssen, Marloes ; Mitta, Surabhi; Zalewski, Paweł ; Meaney, Andy; Wade, Derick ; Izadi, Hooshang ; Winward, Charlotte; Monteiro, Carlos Bandeira de Mello ; Dawes, Helen
Fonte: PLoS One. Unidades: EACH, FM
Assunto: DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Íbis Ariana Peña de et al. Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson’s disease, results from a phase II randomised controlled trial. PLoS One, p. 01-19, 2024Tradução . . Disponível em: http://dx.doi.org/10.1371/journal.pone.0309217. Acesso em: 06 nov. 2024.
APA
Moraes, Í. A. P. de, Collett, J., Silva, T. D. da, Franssen, M., Mitta, S., Zalewski, P., et al. (2024). Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson’s disease, results from a phase II randomised controlled trial. PLoS One, 01-19. doi:10.1371/journal.pone.0309217
NLM
Moraes ÍAP de, Collett J, Silva TD da, Franssen M, Mitta S, Zalewski P, Meaney A, Wade D, Izadi H, Winward C, Monteiro CB de M, Dawes H. Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson’s disease, results from a phase II randomised controlled trial [Internet]. PLoS One. 2024 ; 01-19.[citado 2024 nov. 06 ] Available from: http://dx.doi.org/10.1371/journal.pone.0309217
Vancouver
Moraes ÍAP de, Collett J, Silva TD da, Franssen M, Mitta S, Zalewski P, Meaney A, Wade D, Izadi H, Winward C, Monteiro CB de M, Dawes H. Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson’s disease, results from a phase II randomised controlled trial [Internet]. PLoS One. 2024 ; 01-19.[citado 2024 nov. 06 ] Available from: http://dx.doi.org/10.1371/journal.pone.0309217
Artigo de periodico
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial (2023)
Souza, Rogerio de ; Badesch, David B; Ghofrani, Hossein Ardeschir ; Gibbs, John Simon Russell; Gomberg-Maitland, Mardi; McLaughlin, Vallerie V; Preston, Ioana R; Waxman, Aaron B; Grünig, Ekkehard; Kopeć, Grzegorz
Fonte: European respiratory journal. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, PROTEÍNAS RECOMBINANTES, HEMODINÂMICA, FREQUÊNCIA CARDÍACA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Rogerio de et al. Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial. European respiratory journal, v. 62, n. 3, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57367. Acesso em: 06 nov. 2024.
APA
Souza, R. de, Badesch, D. B., Ghofrani, H. A., Gibbs, J. S. R., Gomberg-Maitland, M., McLaughlin, V. V., et al. (2023). Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial. European respiratory journal, 62( 3). doi:10.1183/13993003.01107-2023
NLM
Souza R de, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Waxman AB, Grünig E, Kopeć G. Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial [Internet]. European respiratory journal. 2023 ; 62( 3):[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57367
Vancouver
Souza R de, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Waxman AB, Grünig E, Kopeć G. Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial [Internet]. European respiratory journal. 2023 ; 62( 3):[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57367
Artigo de periodico
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study (2023)
Dey, Mrinalini ; Naveen, R ; Nikiphorou, Elena ; Sen, Parikshit ; Saha, Sreoshy ; Lilleker, James B ; Agarwal, Vishwesh ; Kardes, Sinan ; Day, Jessica ; Milchert, Marcin ; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology. Unidade: FM
Assuntos: COVID-19, DOENÇAS AUTOIMUNES, VACINAÇÃO, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEY, Mrinalini et al. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. Rheumatology, v. 62, n. 5, p. E147-E152, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53815. Acesso em: 06 nov. 2024.
APA
Dey, M., Naveen, R., Nikiphorou, E., Sen, P., Saha, S., Lilleker, J. B., et al. (2023). Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. Rheumatology, 62( 5), E147-E152. doi:10.1093/rheumatology/keac603
NLM
Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, Kardes S, Day J, Milchert M, Shinjo SK. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study [Internet]. Rheumatology. 2023 ; 62( 5): E147-E152.[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53815
Vancouver
Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, Kardes S, Day J, Milchert M, Shinjo SK. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study [Internet]. Rheumatology. 2023 ; 62( 5): E147-E152.[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53815
Artigo de periodico
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement (2023)
Rosta, Laszlo; Menyhart, Adrienn; Mahmeed, Wael Al; Al-rasadi, Khalid; Al-alawi, Kamila; Banach, Maciej; Banerjee, Yajnavalka; Ceriello, Antonio; Cesur, Mustafa; Cosentino, Francesco; Lotufo, Paulo Andrade; Santos Filho, Raul Dias dos
Fonte: Frontiers in endocrinology. Unidade: FM
Assuntos: DIABETES MELLITUS, COVID-19, TELEMEDICINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSTA, Laszlo et al. Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement. Frontiers in endocrinology, v. 14, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54572. Acesso em: 06 nov. 2024.
APA
Rosta, L., Menyhart, A., Mahmeed, W. A., Al-rasadi, K., Al-alawi, K., Banach, M., et al. (2023). Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement. Frontiers in endocrinology, 14. doi:10.3389/fendo.2023.1129793
NLM
Rosta L, Menyhart A, Mahmeed WA, Al-rasadi K, Al-alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Lotufo PA, Santos Filho RD dos. Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement [Internet]. Frontiers in endocrinology. 2023 ; 14[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54572
Vancouver
Rosta L, Menyhart A, Mahmeed WA, Al-rasadi K, Al-alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Lotufo PA, Santos Filho RD dos. Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement [Internet]. Frontiers in endocrinology. 2023 ; 14[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54572
Artigo de periodico
Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health (2022)
Presti, Elena Lo ; Nuzzo, Domenico ; Mahmeed, Wael Al ; Al-rasadi, Khalid ; Al-alawi, Kamila; Banach, Maciej; Banerjee, Yajnavalka ; Ceriello, Antonio; Cesur, Mustafa ; Cosentino, Francesco
Fonte: Biochimica et biophysica acta-molecular basis of disease. Unidades: FM, EE/EERP
Assuntos: COVID-19, OBESIDADE, FATORES DE RISCO, DOENÇAS METABÓLICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRESTI, Elena Lo et al. Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health. Biochimica et biophysica acta-molecular basis of disease, v. 1868, n. 12, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50403. Acesso em: 06 nov. 2024.
APA
Presti, E. L., Nuzzo, D., Mahmeed, W. A., Al-rasadi, K., Al-alawi, K., Banach, M., et al. (2022). Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health. Biochimica et biophysica acta-molecular basis of disease, 1868( 12). doi:10.1016/j.bbadis.2022.166559
NLM
Presti EL, Nuzzo D, Mahmeed WA, Al-rasadi K, Al-alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F. Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health [Internet]. Biochimica et biophysica acta-molecular basis of disease. 2022 ; 1868( 12):[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50403
Vancouver
Presti EL, Nuzzo D, Mahmeed WA, Al-rasadi K, Al-alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F. Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health [Internet]. Biochimica et biophysica acta-molecular basis of disease. 2022 ; 1868( 12):[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50403
Artigo de periodico
Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease (2022)
Mehanna, Raja ; Smilowska, Katarzyna ; Fleisher, Jori; Post, Bart; Hatano, Taku; Piemonte, Maria Elisa Pimentel ; Kumar, Kishore Raj ; Mcconvey, Victor; Zhang, Baorong ; Tan, Eng-King
Fonte: Movement disorders clinical practice. Unidade: FM
Assuntos: DIAGNÓSTICO PRECOCE, DOENÇA DE PARKINSON, CONSENSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHANNA, Raja et al. Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease. Movement disorders clinical practice, v. 9, n. 7, p. 869-878, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50501. Acesso em: 06 nov. 2024.
APA
Mehanna, R., Smilowska, K., Fleisher, J., Post, B., Hatano, T., Piemonte, M. E. P., et al. (2022). Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease. Movement disorders clinical practice, 9( 7), 869-878. doi:10.1002/mdc3.13523
NLM
Mehanna R, Smilowska K, Fleisher J, Post B, Hatano T, Piemonte MEP, Kumar KR, Mcconvey V, Zhang B, Tan E-K. Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease [Internet]. Movement disorders clinical practice. 2022 ; 9( 7): 869-878.[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50501
Vancouver
Mehanna R, Smilowska K, Fleisher J, Post B, Hatano T, Piemonte MEP, Kumar KR, Mcconvey V, Zhang B, Tan E-K. Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease [Internet]. Movement disorders clinical practice. 2022 ; 9( 7): 869-878.[citado 2024 nov. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50501
Artigo de periodico
Gut dysbiosis in Chagas disease. A possible link to the pathogenesis (2020)
Basqueira, Marcela de Souza ; Ribeiro, Roberto Marques; Oliveira, Léa Campos de; Moreira, Carlos Henrique Valente ; Martins, Roberta Cristina Ruedas; Franco, Diego Castillo ; Amado, Pâmela Pontes Penas ; Mayer, Marcia Pinto Alves ; Sabino, Ester Cerdeira
Fonte: Frontiers in Cellular and Infection Microbiology. Unidades: ICB, FM
Assuntos: MICROBIOLOGIA, DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, FENÓTIPOS, DIVERSIDADE GENÉTICA, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASQUEIRA, Marcela de Souza et al. Gut dysbiosis in Chagas disease. A possible link to the pathogenesis. Frontiers in Cellular and Infection Microbiology, v. 10, p. 8 , 2020Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2020.00402. Acesso em: 06 nov. 2024.
APA
Basqueira, M. de S., Ribeiro, R. M., Oliveira, L. C. de, Moreira, C. H. V., Martins, R. C. R., Franco, D. C., et al. (2020). Gut dysbiosis in Chagas disease. A possible link to the pathogenesis. Frontiers in Cellular and Infection Microbiology, 10, 8 . doi:10.3389/fcimb.2020.00402
NLM
Basqueira M de S, Ribeiro RM, Oliveira LC de, Moreira CHV, Martins RCR, Franco DC, Amado PPP, Mayer MPA, Sabino EC. Gut dysbiosis in Chagas disease. A possible link to the pathogenesis [Internet]. Frontiers in Cellular and Infection Microbiology. 2020 ; 10 8 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.3389/fcimb.2020.00402
Vancouver
Basqueira M de S, Ribeiro RM, Oliveira LC de, Moreira CHV, Martins RCR, Franco DC, Amado PPP, Mayer MPA, Sabino EC. Gut dysbiosis in Chagas disease. A possible link to the pathogenesis [Internet]. Frontiers in Cellular and Infection Microbiology. 2020 ; 10 8 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.3389/fcimb.2020.00402
Artigo de periodico
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial (2017)
Ohman, E. Magnus; Roe, Matthew T.; Steg, P. Gabriel; James, Stefan K.; Povsic, Thomas J.; White, Jennifer; Rockhold, Frank; Plotnikov, Alexei; Mundl, Hardi; Strony, John; Sun, Xiang; Husted, Steen; Tendera, Michal; Montalescot, Gilles; Bahit, M. Cecilia; Ardissino, Diego; Bueno, Héctor; Claeys, Marc J.; Nicolau, Jose C.; Cornel, Jan H.; Goto, Shinya; Kiss, Róbert Gábor; Güray, Ümit; Park, Duk-Woo; Bode, Christoph; Welsh, Robert C.; Gibson, C. Michael
Fonte: Lancet. Unidade: FM
Assuntos: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ANTICOAGULANTES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OHMAN, E. Magnus et al. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, v. 389, n. 10081, p. 1799-1808, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)30751-1. Acesso em: 06 nov. 2024.
APA
Ohman, E. M., Roe, M. T., Steg, P. G., James, S. K., Povsic, T. J., White, J., et al. (2017). Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, 389( 10081), 1799-1808. doi:10.1016/S0140-6736(17)30751-1
NLM
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1
Vancouver
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1
Artigo de periodico
High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial (2017)
Eisen, Alon; Bonaca, Marc P.; Scirica, Benjamin M.; White, Harvey D.; Tendera, Michal; Dellborg, Mikael; Nicolau, Jose C.; Morais, Joao; Fox, Keith A. A.; Bohula, Erin A.; Murphy, Sabina A.; Braunwald, Eugene; Morrow, David A.
Fonte: Clinical Chemistry. Unidade: FM
Assuntos: BIOMARCADOR, TROPONINA, DOENÇAS CARDIOVASCULARES, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EISEN, Alon et al. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clinical Chemistry, v. 63, n. 1, p. 307-315, 2017Tradução . . Disponível em: https://doi.org/10.1373/clinchem.2016.264788. Acesso em: 06 nov. 2024.
APA
Eisen, A., Bonaca, M. P., Scirica, B. M., White, H. D., Tendera, M., Dellborg, M., et al. (2017). High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clinical Chemistry, 63( 1), 307-315. doi:10.1373/clinchem.2016.264788
NLM
Eisen A, Bonaca MP, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KAA, Bohula EA, Murphy SA, Braunwald E, Morrow DA. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial [Internet]. Clinical Chemistry. 2017 ; 63( 1): 307-315.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1373/clinchem.2016.264788
Vancouver
Eisen A, Bonaca MP, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KAA, Bohula EA, Murphy SA, Braunwald E, Morrow DA. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial [Internet]. Clinical Chemistry. 2017 ; 63( 1): 307-315.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1373/clinchem.2016.264788
Artigo de periodico
ESPEN guideline: Clinical nutrition in surgery (2017)
Weimann, Arved; Braga, Marco; Carli, Franco; Higashiguchi, Takashi; Hübner, Martin; Klek, Stanislaw; Laviano, Alessandro; Ljungqvist, Olle; Lobo, Dileep N.; Martindale, Robert; Waitzberg, Dan L.; Bischoff, Stephan C.; Singer, Pierre
Fonte: Clinical nutrition (Edinburgh). Unidade: FM
Assuntos: NUTRIÇÃO PARENTERAL, CUIDADOS PRÉ-OPERATÓRIOS, COMPLICAÇÕES PÓS-OPERATÓRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEIMANN, Arved et al. ESPEN guideline: Clinical nutrition in surgery. Clinical nutrition (Edinburgh), v. 36, n. 3, p. 623-650, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.clnu.2017.02.013. Acesso em: 06 nov. 2024.
APA
Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hübner, M., Klek, S., et al. (2017). ESPEN guideline: Clinical nutrition in surgery. Clinical nutrition (Edinburgh), 36( 3), 623-650. doi:10.1016/j.clnu.2017.02.013
NLM
Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, Laviano A, Ljungqvist O, Lobo DN, Martindale R, Waitzberg DL, Bischoff SC, Singer P. ESPEN guideline: Clinical nutrition in surgery [Internet]. Clinical nutrition (Edinburgh). 2017 ; 36( 3): 623-650.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.clnu.2017.02.013
Vancouver
Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, Laviano A, Ljungqvist O, Lobo DN, Martindale R, Waitzberg DL, Bischoff SC, Singer P. ESPEN guideline: Clinical nutrition in surgery [Internet]. Clinical nutrition (Edinburgh). 2017 ; 36( 3): 623-650.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.clnu.2017.02.013
Artigo de periodico
SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension (2017)
Galiè, Nazzareno; Jansa, Pavel; Pulido, Tomás; Channick Richard N.; Delcroix, Marion; Ghofrani, Hossein-Ardeschir; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loïc; Rubin Lewis J.; Sastry, B.K.S.; Simonneau, Gérald; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam
Fonte: European Heart Journal. Unidade: FM
Assuntos: MORTALIDADE, CATETERISMO CARDÍACO, ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALIÈ, Nazzareno et al. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal, v. 38, n. 15, p. 1147-1155, 2017Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehx025. Acesso em: 06 nov. 2024.
APA
Galiè, N., Jansa, P., Pulido, T., Channick Richard N.,, Delcroix, M., Ghofrani, H. -A., et al. (2017). SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal, 38( 15), 1147-1155. doi:10.1093/eurheartj/ehx025
NLM
Galiè N, Jansa P, Pulido T, Channick Richard N., Delcroix M, Ghofrani H-A, Le Brun F-O, Mehta S, Perchenet L, Rubin Lewis J., Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension [Internet]. European Heart Journal. 2017 ; 38( 15): 1147-1155.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1093/eurheartj/ehx025
Vancouver
Galiè N, Jansa P, Pulido T, Channick Richard N., Delcroix M, Ghofrani H-A, Le Brun F-O, Mehta S, Perchenet L, Rubin Lewis J., Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension [Internet]. European Heart Journal. 2017 ; 38( 15): 1147-1155.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1093/eurheartj/ehx025
Artigo de periodico
Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN (2015)
Simonneau, Gérald; Channick, Richard N.; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein-Ardeschir; Jansa, Pavel; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomás; Sastry, B. K. S.; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam; Rubin, Lewis J.
Fonte: European respiratory journal. Unidade: FM
Assuntos: HIPERTENSÃO PULMONAR, ESTUDOS DE COORTES, FÁRMACOS (SISTEMA RESPIRATÓRIO), ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMONNEAU, Gérald et al. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. European respiratory journal, v. 46, n. 6, p. 1711-1720, 2015Tradução . . Disponível em: https://doi.org/10.1183/13993003.00364-2015. Acesso em: 06 nov. 2024.
APA
Simonneau, G., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H. -A., Jansa, P., et al. (2015). Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. European respiratory journal, 46( 6), 1711-1720. doi:10.1183/13993003.00364-2015
NLM
Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Souza R, Torbicki A, Rubin LJ. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN [Internet]. European respiratory journal. 2015 ; 46( 6): 1711-1720.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1183/13993003.00364-2015
Vancouver
Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Souza R, Torbicki A, Rubin LJ. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN [Internet]. European respiratory journal. 2015 ; 46( 6): 1711-1720.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1183/13993003.00364-2015

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos